You are here

109 Therapeutics, Inc.

Company Information
825 N 300 W Ste 300
Salt Lake City, UT 84103-1459
United States


DUNS: 081318998

# of Employees: 3

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts

Award Listing

  1. SBIR Phase I: Novel injectable long-acting local anesthetic for postoperative pain management

    Amount: $255,838.00

    The broader impact /commercial potential of this Small Business Innovation Research (SBIR) Phase I project develops novel pain therapeutics that can reduce or eliminate the use of opioids after surger ...

    SBIRPhase I2020National Science Foundation
US Flag An Official Website of the United States Government